[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
** Researcher Update
------------------------------------------------------------
** July 2025
------------------------------------------------------------
[link removed]
In this update:
* American Brain Foundation Funding Opportunities ([link removed])
* Webinar on Immigration Strategies for International Research Professionals ([link removed])
* Defining the Landscape of Late-Onset Unexplained Epilepsy Conference ([link removed])
* NIH Blueprint MedTech Program Funding Opportunities ([link removed])
** American Brain Foundation Funding Opportunities
------------------------------------------------------------
The American Brain Foundation has open funding opportunities, including:
* Cure One, Cure Many Award: Neuroinflammation ([link removed]) – $5 million available
This program focuses on advancing our understanding of neuroinflammation as a common mechanism across various brain diseases.
+ Pre-Proposal Deadline: July 15
* Next Generation Research Grants ([link removed]) – 14 grants available for early career researchers
These grants are designed to support early career researchers in brain disease fields, helping them gain critical preliminary data for future, larger-scale funding. 98% of recipients have gone on to secure additional research funding.
+ Application Deadline: September 9
Cure One, Cure Many ([link removed])
Next Generation Research Grants ([link removed])
** Webinar on immigration strategies for international research professionals
------------------------------------------------------------
HRA and Talent Mobility Fund are hosting a webinar ([link removed]) exploring immigration strategies designed specifically for the unique needs of professionals working in the research ecosystem. Three leading immigration experts will provide practical guidance on navigating the complex US immigration landscape, with a focus on pathways that enable talented researchers and professionals to build long-term careers in the US research community.
Whether you’re a postdoc, research scientist, investigator, or supporting biomedical innovation in another capacity, this session can offer valuable information and actionable insights.
Learn More ([link removed])
** Defining the Landscape of Late-Onset Unexplained Epilepsy Conference
------------------------------------------------------------
We’re proud to sponsor the Epilepsy Foundation New England’s conference, Defining the Landscape of Late-Onset Unexplained Epilepsy ([link removed]) , happening October 15–17 at the Migis Lodge at Sebago Lake in South Casco, Maine.
This multidisciplinary conference will convene physicians and scientists to explore emerging research topics relevant to late-onset unexplained epilepsy (LoUE). The program will feature presentations from leading experts in the fields of epilepsy, neurodegenerative disease, and vascular disease, along with lively discussion and debate, to share knowledge and resources, foster collaboration, and establish future research priorities.
This will be a small but highly interactive conference (65 attendees). Apply to participate and help shape the future of LoUE research!
Learn More ([link removed])
** NIH Blueprint MedTech Program Funding Opportunities
------------------------------------------------------------
Apply for funding from NIH Blueprint MedTech ([link removed]) incubator hubs, Cimit's CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program. They are seeking pre-proposals from academic, industry, and nonprofit applicants who have emerging preventative, therapeutic, or diagnostic medical devices focused on disorders of the nervous system. There is a two-stage process for awards:
* Sprinter: Sprinter awards provide $100,000 in support over 20-weeks to focus on identifying and undertaking the first critical steps towards product development. Mentors will work with awardees throughout to help resolve identified gaps on the path to commercialization in advance of a Deep Dive evaluation.
* Optimizer: Optimizer awards up to $1.285M for one year will be awarded to the most promising technologies after a Deep Dive evaluation. These awards help accelerate development toward commercialization. In addition to funding, awardees will have access to resources and support services as well as ongoing specialized support from mentors with deep expertise in commercializing medical devices.
Learn More ([link removed])
** Want to keep up-to-date on funding and professional development opportunities? Follow us on LinkedIn here! ([link removed])
------------------------------------------------------------
Our mission is to fund breakthrough research that will transform the lives of people with epilepsy as we lead the search for a cure. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
Donate ([link removed])
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
[link removed]
Copyright (C) 2024 CURE Epilepsy. All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
View in browser ([link removed]) | Add us to your address book ([link removed])
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])
